Eczema Market Report 2026

Eczema Market Overview

• Eczema market size has reached to $17.76 billion in 2025 • Expected to grow to $25.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Increasing Prevalence Of Autoimmune Disorders Driving Growth In The Market • Market Trend: Development Of Innovative Eczema Care Creams • North America was the largest region in 2025.

What Is Covered Under Eczema Market?

Eczema is a chronic inflammatory skin condition characterized by redness, itching, dryness, and irritation. It occurs due to genetic and environmental factors, leading to a compromised skin barrier and an overactive immune response. Eczema can affect people of all ages but is more common in children. The condition may present in flare-ups triggered by allergens, irritants, stress, or climate changes. The main types of eczema are atopic dermatitis, contact dermatitis, seborrheic dermatitis, and other types. atopic dermatitis, or eczema, is a chronic skin condition characterized by itchy, red, and inflamed skin, often triggered by allergens, irritants, or stress. Treatments for eczema include topical treatments, oral medications, biologics, and phototherapy. Eczema affects various age groups, including children, adults, and the elderly. It is treated by various end users, such as hospitals, clinics, dermatology centers, home care settings, and pharmacies.

What Is The Eczema Market Growth Forecast?

The eczema market size is expected to see strong growth in the next few years. It will grow to $25.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to targeted biologics adoption, personalized dermatology treatments, digital dermatology platforms, pediatric care expansion, lifestyle-related flare management. Major trends in the forecast period include increasing use of biologic therapies, growing demand for topical non-steroidal treatments, rising awareness of chronic skin conditions, expansion of pediatric eczema management, improved focus on long-term disease control.

Global Eczema Market Segmentation

1) By Type: Atopic Dermatitis, Contact Dermatitis, Seborrheic Dermatitis, Other Types 2) By Treatment Type: Topical Treatments, Oral Medications, Biologics, Phototherapy 3) By Age Group: Children, Adults, Elderly 4) By End User: Hospitals Or Clinics, Dermatology Centers, Home Care, Pharmacies Subsegments: 1) By Atopic Dermatitis: Topical Steroids, Topical Calcineurin Inhibitors, Moisturizers, Biologic Therapies 2) By Contact Dermatitis: Topical Steroids, Antihistamines, Topical Immunosuppressants, Wet Compresses 3) By Seborrheic Dermatitis: Antifungal Creams or Shampoos, Topical Steroids, Medicated Shampoos, Topical Calcineurin Inhibitors 4) By Other Types: Allergic Dermatitis, Nummular Dermatitis, Neurodermatitis, Dyshidrotic Eczema

What Is The Driver Of The Eczema Market?

The increasing prevalence of autoimmune disorders is expected to propel the growth of the eczema market going forward. Autoimmune disorders refer to conditions in which the body's immune system mistakenly attacks its healthy cells, tissues, or organs, leading to inflammation and damage. The increasing prevalence of autoimmune disorders is attributed to genetic susceptibility, environmental factors, infections, dietary changes, and lifestyle factors such as stress and exposure to pollutants. Autoimmune diseases, such as psoriasis, lupus, and rheumatoid arthritis, are linked to dysregulated immune responses, making individuals more susceptible to eczema and other inflammatory skin conditions. For instance, in February 2024 according to the Arthritis Australia is a Australia-based non-profit organization In 2025, an estimated 212,136 males and 362,137 females are projected to have rheumatoid arthritis (RA), with the numbers expected to rise by 2040 to approximately 280,040 males and 479,828 females. Therefore, the increasing prevalence of autoimmune disorders is driving the growth of the eczema industry.

Key Players In The Global Eczema Market

Major companies operating in the eczema market are Pfizer Inc., AbbieVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Amgen, Hoffmann-La Roche AG, Eli Lilly and Co., Siemens Healthineers AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc, Bausch Health Companies Inc., Galderma, Cadila Pharmaceuticals Ltd., LEO Pharma A/S, Almirall, Kyowa Kirin, Alliance Pharma Plc, Encore Dermatology Inc., Arcutis Inc

Global Eczema Market Trends and Insights

Major companies operating in the eczema market are focusing on the development of innovative products, such as eczema care creams, to enhance treatment effectiveness and meet consumer demand for advanced skincare solutions. Eczema care cream is a specialized skincare product designed to soothe, hydrate, and protect the skin affected by eczema, helping to reduce itching, inflammation, and dryness. For instance, in September 2024, Dove, a UK-based personal care brand, launched a new Eczema Care range for babies, which includes the Baby Dove Eczema Care Soothing Bath Treatment and the Baby Dove Eczema Care Cream. The Baby Dove Eczema Care range offers several unique features tailored for infants with eczema. Firstly, the products are formulated with 100% skin-natural nutrients, ensuring they are gentle on sensitive skin. They contain colloidal oatmeal (1.0%), a key ingredient for soothing irritation and maintaining moisture.

What Are Latest Mergers And Acquisitions In The Eczema Market?

In May 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Proteologix Inc. for approximately $850 million. With this acquisition, Johnson & Johnson aims to enhance its leadership in treating atopic dermatitis (AD) and asthma by integrating innovative bispecific antibody therapies into its portfolio. Proteologix Inc. is a US-based biotechnology company specializing in bispecific antibodies for immune-mediated diseases.

Regional Outlook

North America was the largest region in the eczema market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Eczema Market?

The eczema market consists of revenues earned by entities by providing services such as diagnosis and consultation services, prescription and medication services, phototherapy services, allergy testing and immunotherapy, and skin barrier repair therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The eczema market also includes sales of antihistamines, topical corticosteroids, calcineurin inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Eczema Market Report 2026?

The eczema market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the eczema industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.